MATVMativ Holdings, Inc.

$11.89+14% 1Y

$11.89

$7.2152 weeks$14.72

Is the price fair?

Good

Undemanding: modest expectations priced in and cheap against its own history.

2 good, 1 without data

What the price assumes~−13% a yearderived · Jun 30, 2026

Priced for a decline (~−13% a year). Little growth is priced in even as revenue fell 3% a year over three years, potential value, or a value trap.

Vs its own P/E rangecheaper than 83% of its own historyderived

Cheap vs its own history: P/E 7.3 vs a 10.4 median over 29 quarters (−30% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

Mativ Holdings, Inc. trades at 7.29× earnings against 29.6× for the median Specialty Chemicals name, cheaper than its own group.

7.29

Trailing P/E · Specialty Chemicals median 29.6 · cheaper than the typical name in its group

Price / sales: 0.24
Price / sales · as of 2026-Q1
Free cash flow yield: 19%
Free cash flow yield · Specialty Chemicals median 4.7%
Growth the price implies: −13%
Growth the price implies · The price pays for −13% free cash flow growth a year for a decade; the business has delivered −3.3% a year over the last three.

Details›

What the market has paid for these earnings: 29 quarters of its own multiple × $1.63 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$13.67
Its own P/E history, median	$16.96
Its own P/E history, upper quartile	$18.97
52-week range	$7.21 – $14.72
Today	$11.89

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Ranks #26 of 33 by RyuScore